dc.contributor.author
Hernandez-Rubio, Anna
dc.contributor.author
Sanvisens, Arantza
dc.contributor.author
Bolao, Ferran
dc.contributor.author
Pérez-Mañá, Clara
dc.contributor.author
García-Marchena, Nuria
dc.contributor.author
Fernández-Prendes, Carla
dc.contributor.author
Muñoz, Alvaro
dc.contributor.author
Muga, Roberto
dc.contributor.author
Universitat Autònoma de Barcelona
dc.identifier
https://ddd.uab.cat/record/280990
dc.identifier
urn:10.1038/s41598-023-31311-6
dc.identifier
urn:oai:ddd.uab.cat:280990
dc.identifier
urn:pmcid:PMC10014964
dc.identifier
urn:pmc-uid:10014964
dc.identifier
urn:oai:pubmedcentral.nih.gov:10014964
dc.identifier
urn:pmid:36918703
dc.identifier
urn:oai:egreta.uab.cat:publications/36c27f67-7920-4b42-aaaa-fde2c6f9db60
dc.description.abstract
Excessive alcohol consumption leads to overproduction of urates and renal function plays a critical role in serum uric acid levels. We aimed to assess associations of hyperuricemia in patients with alcohol use disorder (AUD) and comparable Glomerular Filtration Rate (GFR). A total of 686 patients undergoing treatment for AUD between 2013 and 2017 were eligible (77% men); age at admission was 47 years [interquartile range (IQR), 40-53 years], age of onset of alcohol consumption was 16 years [IQR, 16-18 years] and the amount of alcohol consumed was 160 g/day [IQR, 120-240 g/day]. Body Mass Index was 24.7 kg/m2 [IQR, 21.9-28.4 kg/m2], eGFR was 105 mL/min/1.73 m2 [IQR, 95.7-113.0 mL], 9.7% had metabolic syndrome and 23% had advanced liver fibrosis (FIB-4 > 3.25). Prevalence of hyperuricemia was 12.5%. The eGFR-adjusted multivariate analysis showed that relative to patients with GGT ≤ 50, those with GGT between 51 and 300 U/L and those with GGT > 300 U/L were 4.31 (95% CI 1.62-11.46) and 10.3 (95% CI 3.50-29.90) times more likely to have hyperuricemia, respectively. Our data shows that hyperuricemia in the context of AUD is strongly associated with serum GGT levels and suggest an increased cardio-metabolic risk in this population.
dc.format
application/pdf
dc.relation
Scientific reports ; Vol. 13 (march 2023)
dc.rights
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
dc.rights
https://creativecommons.org/licenses/by/4.0/
dc.subject
Metabolic disorders
dc.title
Author Correction : Association of hyperuricemia and gamma glutamyl transferase as a marker of metabolic risk in alcohol use disorder